Literature DB >> 1284205

Distribution of neuropeptides in rat pterygopalatine ganglion: light and electron microscopic immunohistochemical studies.

H Motosugi1, T Chiba, A Konno, T Kaneko.   

Abstract

The distribution and quantity of neuropeptides in the rat pterygopalatine ganglion were studied by using complete serial paraffin sections of the ganglion immunostained with antiserum against several neuropeptides. The pterygopalatine ganglion, composed of 4932 +/- 291 (mean +/- SD) neurons, was triangular in shape with a tapering caudal tail. The most commonly found peptide in neurons was vasoactive intestinal polypeptide (VIP) (99.0%), followed by neuropeptide Y (NPY) (54.1%) and enkephalin (10.5%). The rostro-ventromedial and caudal parts of the ganglion where intensely VIP-immunoreactive neurons predominate project to the nasal mucosa, while the rostro-dorsolateral part of the ganglion where NPY-immunoreactive neurons predominate projects to the Harderian gland. The coexistence of VIP/NPY (47.4%), VIP/NPY/enkephalin (6.6%) or VIP/enkephalin (3.9%) in the ganglionic neurons was recognized. Calcitonin gene-related peptide (CGRP)- and substance P-immunoreactive varicosities formed synaptic contacts with the somatic spine or soma, which confirmed that the reflex arch, composed of axon collaterals of trigeminal ganglionic neurons and parasympathetic ganglionic neurons, operates through direct synapses. Enkephalin-immunoreactive varicosities, which were probably derived from parasympathetic preganglionic neurons, also made synaptic contact with the somatic spine.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1284205     DOI: 10.1679/aohc.55.513

Source DB:  PubMed          Journal:  Arch Histol Cytol        ISSN: 0914-9465


  3 in total

1.  5-HT(1D) receptor immunoreactivity in the sphenopalatine ganglion: implications for the efficacy of triptans in the treatment of autonomic signs associated with cluster headache.

Authors:  Jason J Ivanusic; Matthew M K Kwok; Andrew H Ahn; Ernest A Jennings
Journal:  Headache       Date:  2011-03       Impact factor: 5.887

2.  The Anti-CGRP Antibody Fremanezumab Lowers CGRP Release from Rat Dura Mater and Meningeal Blood Flow.

Authors:  Mária Dux; Birgit Vogler; Annette Kuhn; Kimberly D Mackenzie; Jennifer Stratton; Karl Messlinger
Journal:  Cells       Date:  2022-05-28       Impact factor: 7.666

3.  Electrophysiological and immunofluorescence characterization of Ca(2+) channels of acutely isolated rat sphenopalatine ganglion neurons.

Authors:  Wojciech Margas; Victor Ruiz-Velasco
Journal:  Neurosci Lett       Date:  2007-05-04       Impact factor: 3.046

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.